Lixte Biotechnology (LIXT) Q1 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1
-0.8
-0.61
-0.41

Details

Expected EPS
N/A
Actual EPS
-0.43
Surprise EPS
-0.43
Surprise Percent
+∞%

Description

Lixte Biotechnology (LIXT) has reported earnings of -0.43 per share for Q1 2024.

0 Comments

Share your thoughts